9-03-2026, 20:00

Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications

Notified -
Globe Newswire9-03-2026, 20:00
25-11-2025, 08:24

Junshi Biosciences Announces Primary Endpoints Met in JS001sc’s Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC

Notified -
Globe Newswire25-11-2025, 08:24